454 related articles for article (PubMed ID: 8783784)
21. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology.
Reiter RJ; Tan DX; Korkmaz A; Rosales-Corral SA
Hum Reprod Update; 2014; 20(2):293-307. PubMed ID: 24132226
[TBL] [Abstract][Full Text] [Related]
22. Plasma angiotensin I concentration and serum placental leucine aminopeptidase (P-LAP) activities in puerperal hypertension.
Mizutani S; Tomoda Y
Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):271-91. PubMed ID: 8235062
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural localization of aminopeptidase A/angiotensinase and placental leucine aminopeptidase/oxytocinase in chorionic villi of human placenta.
Ito N; Nomura S; Iwase A; Ito T; Ino K; Nagasaka T; Tsujimoto M; Kobayashi M; Mizutani S
Early Hum Dev; 2003 Feb; 71(1):29-37. PubMed ID: 12614948
[TBL] [Abstract][Full Text] [Related]
24. Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy.
Nomura S; Ito T; Yamamoto E; Sumigama S; Iwase A; Okada M; Shibata K; Ando H; Ino K; Kikkawa F; Mizutani S
Biochim Biophys Acta; 2005 Aug; 1751(1):19-25. PubMed ID: 15894523
[TBL] [Abstract][Full Text] [Related]
25. Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia.
Pertegal M; Fenoy FJ; Hernández M; Mendiola J; Delgado JL; Bonacasa B; Corno A; López B; Bosch V; Hernández I
Fertil Steril; 2016 Jan; 105(1):134-43.e1-3. PubMed ID: 26450530
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?
Walsh SW; Strauss JF
Am J Obstet Gynecol; 2022 Feb; 226(2S):S945-S953. PubMed ID: 35177224
[TBL] [Abstract][Full Text] [Related]
27. Leucine aminopeptidase activity in maternal, cord blood and placenta of normal pregnancy and in pre-eclampsia.
Ibrahim FK; Fattah MM; Ramadan MA; Sammour MB
Acta Obstet Gynecol Scand; 1976; 55(1):45-7. PubMed ID: 1251692
[TBL] [Abstract][Full Text] [Related]
28. A proposed relationship between vasopressinase altered vasopressin and preeclampsia.
Krege JH; Katz VL
Med Hypotheses; 1990 Apr; 31(4):283-7. PubMed ID: 2192237
[TBL] [Abstract][Full Text] [Related]
29. Differential responses of mesenteric arterial bed to vasoactive substances in L-NAME-induced preeclampsia: Role of oxidative stress and endothelial dysfunction.
Amaral TAS; Ognibene DT; Carvalho LCRM; Rocha APM; Costa CA; Moura RS; Resende AC
Clin Exp Hypertens; 2018; 40(2):126-135. PubMed ID: 28726518
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the angiotensin-II receptor in placental vascular endothelial cells in preeclamptic and normotensive patients.
Laskowska M; Vinson GP; Szumiło J; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2003; 56(1):55-60. PubMed ID: 12897464
[TBL] [Abstract][Full Text] [Related]
31. Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia.
Kaartokallio T; Utge S; Klemetti MM; Paananen J; Pulkki K; Romppanen J; Tikkanen I; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Lakkisto P; Laivuori H
Hypertension; 2018 Jan; 71(1):95-102. PubMed ID: 29203625
[TBL] [Abstract][Full Text] [Related]
32. Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse.
Čonka J; Konečná B; Lauková L; Vlková B; Celec P
Placenta; 2017 Apr; 52():100-105. PubMed ID: 28454691
[TBL] [Abstract][Full Text] [Related]
33. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.
Burke SD; Zsengellér ZK; Khankin EV; Lo AS; Rajakumar A; DuPont JJ; McCurley A; Moss ME; Zhang D; Clark CD; Wang A; Seely EW; Kang PM; Stillman IE; Jaffe IZ; Karumanchi SA
J Clin Invest; 2016 Jul; 126(7):2561-74. PubMed ID: 27270170
[TBL] [Abstract][Full Text] [Related]
34. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
Nonn O; Fischer C; Geisberger S; El-Heliebi A; Kroneis T; Forstner D; Desoye G; Staff AC; Sugulle M; Dechend R; Pecks U; Kollmann M; Stern C; Cartwright JE; Whitley GS; Thilaganathan B; Wadsack C; Huppertz B; Herse F; Gauster M
Hypertension; 2021 May; 77(5):1723-1736. PubMed ID: 33775117
[TBL] [Abstract][Full Text] [Related]
35. Effect of angiotensin II infusion during normal pregnancy on flow velocity waveforms in the uteroplacental and umbilical circulations.
Jones DC; Sanchez-Ramos L
Obstet Gynecol; 1990 Dec; 76(6):1093-6. PubMed ID: 2234719
[TBL] [Abstract][Full Text] [Related]
36. Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia.
Jouppila P; Kirkinen P; Koivula A; Ylikorkala O
Am J Obstet Gynecol; 1985 Mar; 151(5):661-5. PubMed ID: 3883781
[TBL] [Abstract][Full Text] [Related]
37. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models.
Khalil RA; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R29-45. PubMed ID: 12069928
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
39. Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.
Kalenga MK; Thomas K; de Gasparo M; De Hertogh R
Clin Endocrinol (Oxf); 1996 Apr; 44(4):429-33. PubMed ID: 8706309
[TBL] [Abstract][Full Text] [Related]
40. Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia.
Mizutani S; Akiyama H; Kurauchi O; Taira H; Narita O; Tomoda Y
Arch Gynecol; 1985; 236(3):165-72. PubMed ID: 4015192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
